|
End-of-day quote
Shanghai S.E.
18/08/2026
|
5-day change | 1st Jan Change | ||
| 12.72 CNY | -4.43% |
|
+0.55% | +8.72% |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 05-25 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 5.15B 763M 659M 620M 564M 1.06B 73.15B 1.08B 7.28B 2.85B 36.58B 2.87B 2.8B 122B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.5B 815M 704M 662M 602M 1.13B 78.1B 1.15B 7.77B 3.05B 39.06B 3.06B 2.99B 130B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | -4.43% | ||
| 1 week | +0.55% | ||
| Current month | +23.74% | ||
| 1 month | +16.16% | ||
| 3 months | -1.09% | ||
| 6 months | +6.18% | ||
| Current year | +8.72% |
| 1 week | 12.5 |  | 13.71 |
| 1 month | 9.51 | | 13.71 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 27/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 01/09/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Hai Zhang
CHM | Chairman | 41 | 01/03/2018 |
Qian Fan Zhang
BRD | Director/Board Member | 41 | 01/03/2018 |
Yong Jian Sheng
BRD | Director/Board Member | 52 | 28/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/11/24 A | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 8/2/24 A | Buy | Director | 13,000 | 0.0032% | ||
| 8/5/23 A | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.43% | +0.55% | -2.68% | -17.67% | 763M | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,093B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 653B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 458B | |
| +1.35% | -2.17% | +40.98% | +41.50% | 355B | |
| +1.75% | -0.24% | +25.28% | +40.46% | 294B | |
| +2.13% | -0.32% | +0.58% | +10.77% | 248B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 230B | |
| +1.35% | -3.53% | -14.72% | -52.63% | 203B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 178B | |
| Average | +1.72% | +0.18% | +27.11% | +42.78% | 371.12B | |
| Weighted average by Cap. | +2.79% | +0.25% | +43.85% | +68.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 318M 275M 258M 235M 442M 30.47B 448M 3.03B 1.19B 15.24B 1.19B 1.17B 50.76B | 1.7B 253M 218M 205M 186M 351M 24.19B 356M 2.41B 943M 12.1B 948M 927M 40.31B |
| Net income | 274M 40.64M 35.1M 33.02M 30.01M 56.45M 3.89B 57.28M 387M 152M 1.95B 153M 149M 6.49B | 46.25M 6.86M 5.92M 5.57M 5.07M 9.53M 657M 9.67M 65.38M 25.62M 329M 25.75M 25.19M 1.09B |
| Net Debt | 108M 15.97M 13.79M 12.97M 11.79M 22.18M 1.53B 22.5M 152M 59.64M 765M 59.94M 58.64M 2.55B | 349M 51.71M 44.66M 42.02M 38.19M 71.83M 4.95B 72.88M 493M 193M 2.48B 194M 190M 8.25B |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | CN¥12.72 | -4.43% | 18,524,153 |
| 17/08/26 | CN¥13.31 | -1.63% | 23,809,024 |
| 14/08/26 | CN¥13.53 | +4.64% | 29,785,385 |
| 13/08/26 | CN¥12.93 | +2.62% | 18,411,600 |
| 12/08/26 | CN¥12.60 | -0.40% | 25,392,910 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
